These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11103915)

  • 1. Contextual fear conditioning and baseline startle responses in the rat fear-potentiated startle test: a comparison of benzodiazepine/gamma-aminobutyric acid-A receptor agonists.
    Guscott MR; Cook GP; Bristow LJ
    Behav Pharmacol; 2000 Sep; 11(6):495-504. PubMed ID: 11103915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contribution of contextual fear in the anxiolytic effect of chlordiazepoxide in the fear-potentiated startle test.
    Zhao Y; Bijlsma EY; Verdouw PM; Garssen J; Groenink L
    Behav Brain Res; 2018 Nov; 353():57-61. PubMed ID: 29969605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of fear-potentiated startle by benzodiazepines in C57BL/6J mice.
    Smith KS; Meloni EG; Myers KM; Van't Veer A; Carlezon WA; Rudolph U
    Psychopharmacology (Berl); 2011 Feb; 213(4):697-706. PubMed ID: 20922362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The GABA(B) receptor positive modulator BHF177 attenuated anxiety, but not conditioned fear, in rats.
    Li X; Kaczanowska K; Finn MG; Markou A; Risbrough VB
    Neuropharmacology; 2015 Oct; 97():357-64. PubMed ID: 26002628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anxiolytic action of mGlu2/3 receptor agonist, LY354740, in the fear-potentiated startle model in rats is mechanistically distinct from diazepam.
    Tizzano JP; Griffey KI; Schoepp DD
    Pharmacol Biochem Behav; 2002 Sep; 73(2):367-74. PubMed ID: 12117591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The brain orexin system and almorexant in fear-conditioned startle reactions in the rat.
    Steiner MA; Lecourt H; Jenck F
    Psychopharmacology (Berl); 2012 Oct; 223(4):465-75. PubMed ID: 22592903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favoured genetic background for testing anxiolytics in the fear-potentiated and light-enhanced startle paradigms in the rat.
    Steiner MA; Lecourt H; Rakotoariniaina A; Jenck F
    Behav Brain Res; 2011 Aug; 221(1):34-42. PubMed ID: 21354212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control conditions in the fear-potentiated startle response paradigm.
    Joordens RJ; Hijzen TH; Peeters BW; Olivier B
    Neuroreport; 1997 Mar; 8(4):1031-4. PubMed ID: 9141086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GABA-A and 5-HT1A receptor agonists block expression of fear-potentiated startle in mice.
    Risbrough VB; Brodkin JD; Geyer MA
    Neuropsychopharmacology; 2003 Apr; 28(4):654-63. PubMed ID: 12655310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No effect of sex and estrous cycle on the fear potentiated startle response in rats.
    Zhao Y; Bijlsma EY; Verdouw MP; Groenink L
    Behav Brain Res; 2018 Oct; 351():24-33. PubMed ID: 29803653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiolytic-like property of risperidone and olanzapine as examined in multiple measures of fear in rats.
    Sun T; He W; Hu G; Li M
    Pharmacol Biochem Behav; 2010 May; 95(3):298-307. PubMed ID: 20167232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral and pharmacological validation of an integrated fear-potentiated startle and prepulse inhibition paradigm.
    Zhang M; Li M
    Behav Brain Res; 2016 Jul; 307():176-85. PubMed ID: 27059335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anxiolytic effect on the fear-potentiated startle is not due to a non-specific disruption.
    Joordens RJ; Hijzen TH; Olivier B
    Life Sci; 1998; 63(25):2227-32. PubMed ID: 9870708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular and somatic startle and defense: concordant and discordant actions of benzodiazepine receptor agonists and inverse agonists.
    Hart S; Sarter M; Berntson GG
    Behav Brain Res; 1998 Feb; 90(2):175-86. PubMed ID: 9521549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiolytic-like effects of the neurokinin 1 receptor antagonist GR-205171 in the elevated plus maze and contextual fear-potentiated startle model of anxiety in gerbils.
    Heldt SA; Davis M; Ratti E; Corsi M; Trist D; Ressler KJ
    Behav Pharmacol; 2009 Oct; 20(7):584-95. PubMed ID: 19675456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacological properties of the imidazobenzodiazepine, FG 8205, a novel partial agonist at the benzodiazepine receptor.
    Tricklebank MD; Honoré T; Iversen SD; Kemp JA; Knight AR; Marshall GR; Rupniak NM; Singh L; Tye S; Watjen F
    Br J Pharmacol; 1990 Nov; 101(3):753-61. PubMed ID: 1963808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nonextinction procedure for long-term studies of classically conditioned enhancement of acoustic startle in the rat.
    Winston CR; Leavell BJ; Ardayfio PA; Beard C; Commissaris RL
    Physiol Behav; 2001 May; 73(1-2):9-17. PubMed ID: 11399289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fear-potentiated startle and light-enhanced startle models in drug discovery.
    Groenink L; Bijlsma EY; Olivier B
    Curr Protoc Pharmacol; 2008 Jun; Chapter 5():Unit5.48. PubMed ID: 22294228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzodiazepine-induced anxiolysis and reduction of conditioned fear are mediated by distinct GABAA receptor subtypes in mice.
    Smith KS; Engin E; Meloni EG; Rudolph U
    Neuropharmacology; 2012 Aug; 63(2):250-8. PubMed ID: 22465203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neurotensin-1 receptor agonist PD149163 blocks fear-potentiated startle.
    Shilling PD; Feifel D
    Pharmacol Biochem Behav; 2008 Oct; 90(4):748-52. PubMed ID: 18577396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.